Skip to main content

Table 1 Frequency of autoantibody in sera from patients with lung cancer

From: CIP2A overexpression induces autoimmune response and enhances JNK signaling pathway in human lung cancer

Type of diseases

No. tested

Frequency (Patients with autoantibody/total patients with disease)

Lung Cancer

102

48.0 % (49/102)**a

Normal human sera (NHS)

82

6.1 % (5/82)

  1. a P value relative to NHS: * p < 0.05; ** p < 0.01
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us